Development and evaluation of a kit formulation for the preparation of (99m)Tc-DMP-HSA, a new tracer agent for radionuclide ventriculography

Nuclear Medicine and Biology

Volumn 24, Issue 6, 1997, Pages 571-578

  Verbeke, Kristin A ^a   Schiepers, Christiaan W ^b   Wyndaele, Dirk N ^b   Baetens, Jan A ^b   Verbeke, Geert N ^a   De Roo, Michel J ^b   Verbruggen, Alfons M ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

(99m)Tc DMP HSA; 2,3 Dimercaptopropionyl human serum albumin; Kit formulation; Technetium 99m labeled red blood cells; Technetium 99m; Ventriculography

Indexed keywords

2,3 DIMERCAPTOPROPIONYL HUMAN SERUM ALBUMIN TC 99M; DRUG ADDITIVE; ERYTHROCYTE TC 99M; HUMAN SERUM ALBUMIN TC 99M; TRACER; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SYNTHESIS; FREEZE DRYING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NORMAL HUMAN; RADIATION DOSE; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE VENTRICULOGRAPHY; URINARY EXCRETION; VOLUNTEER;

HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; QUALITY CONTROL; RADIATION DOSAGE; RADIONUCLIDE VENTRICULOGRAPHY; REAGENT KITS, DIAGNOSTIC; SULFHYDRYL COMPOUNDS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0030766426     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00019-X     Document Type: Article

References (28)

1. Adalet I. and Cantez S. (1994) Poor-quality red blood cell labelling with technetium-99m: Case report and review of the literature. Eur. J. Nucl. Med. 21, 173-175.
2. Bogdanov A. A., Callahan R. J., Wilkinson R. A. et al. (1994) Synthetic copolymer kit for radionuclide blood-pool imaging. J. Nucl. Med. 35, 1880-1886.
3. Carpenter J. F. and Crowe J. H. (1988) Modes of stabilization of a protein by organic solutes during desiccation. Cryobiology 25, 459-470.
4. Carpenter J. F., Arakawa T. and Crowe J. H. (1991) Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Dev. Biol. Stand. 74, 225-239.
5. Cleland W. W. (1964) Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3, 480-482.
6. Crowe J. H. and Clegg J. S. (1973) Anhydrobiosis. Dowden, Hutchinson & Ross, Strassbourg.
7. Crowe J. H. and Clegg J. S. (1978) Dry Biological Systems. Academic Press, New York.
8. Ercan M. T. (1992) Rapid determination of hydrolyzed-reduced technetium-99m in particulate radiopharmaceuticals. Appl. Radiat. Isot. 43, 1175-1177.
9. Hambye A. S., Vandermeiren R., Vervaet A. and Vandevivere J. (1995) Failure to label red blood cells adequately in daily practice using an in vivo method: Methodological and clinical considerations. Eur. J. Nucl. Med. 22, 61-67.
10. Hambye A. S., Verbeke K. A., Vandermeiren R. P., Joosens E. J., Verbruggen A. M. and De Roo M. J. (1997) Comparison of modified Tc-99m albumin and Tc-99m RBC for equilibrium ventriculography. J. Nucl. Med. 38 (in press).
11. Henze E., Robinson G. D., Kuhl D. E. and Schelbert H. R. (1982) Tc-99m dextran: A new blood-pool-labeling agent for radionuclide angiocardiography. J. Nucl. Med. 23, 348-353.
12. Hladik W. B., Nigg K. K. and Rhodes B. H. (1982) Drug-induced changes in the biologic distribution of radiopharmaceuticals. Semin. Nucl. Med. 12, 184-218.
13. Lee H. B. and Wexler J. (1983) Pharmacologic alterations in Tc-99m binding by red blood cells: Concise communication. J. Nucl. Med. 24, 397-401.
14. Leitl G. P., Drew H. M., Kelly M. E. and Alderson P. O. (1980) Interference with Tc-99m labeling of red blood cells (RBCs) by RBC antibodies. J. Nucl. Med. 21, 44P.
15. Pauwels E. K. J., Feitsma R. I. J. and Blom J. (1983) Influence of adriamycin on red blood cells labeling: A pitfall in scintigraphic blood pool imaging. Nucl. Med. Commun. 4, 290-293.
16. Peters T. (1970) Serum albumin. Adv. Clin. Chem. 13P, 37-111.
17. 99mTc as blood pool agent. J. Nucl Med. 33, 42P.
18. Prestrelski S. J., Tedeschi N., Arakawa T. and Carpenter J. F. (1993) Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys. J. 65, 661-671.
19. Schwars A. and Steinsträsser A. (1987) A novel approach to Tc-99m-labeled monoclonal antibodies. J. Nucl. Med. 28, 721.
20. Subramanian G., Thomas F. D., Karczewski D., Fantinato L. and Gagne G. (1993) Tc-99m HSA revisited: New methods for labeling. J. Nucl. Med. 34, 97P.
21. Thakur M. L., DeFulvio J. and Park C. H. (1990) Use of ascorbic acid for direct Tc-99m labeling of monoclonal antibodies (MAbs). Eur. J. Nucl. Med. 16, 392.
22. Thrall J. H., Freitas J. E., Swanson D., Rogers W. L., Clare J. M., Brown M. L., et al. (1978) Clinical comparison of cardiac blood pool visualization and technetium-99m-red blood cells labeled in vivo and with technetium-99m-human serum albumin. J. Nucl. Med. 19, 796-803.
23. Tilcock C., Ahkong Q. F. and Fisher D. (1993) Polymer-derivatized technetium-99m-labeled liposomal blood pool agents for nuclear medicine applications. Biochem. Biophys. Acta 1148, 77-84.
24. Vanbilloen H. P., Verbeke K. A., De Roo M. J. and Verbruggen A. M. (1993) Technetium-99m-labelled human serum albumin for ventriculography: A comparative evaluation of six labelling kits. Eur. J. Nucl. Med. 20, 465-472.
25. Verbeke K. A., Vanbilloen H. P., De Roo M. J. and Verbruggen A. M. (1993) Technetium-99m mercaptoalbumin as a potential substitute for technetium-99m-labelled red blood cells. Eur. J. Nucl. Med. 20, 473-482.
26. Verbeke K. A., Vanhecke W. J., Mortelmans L. A. and Verbruggen A. M. (1994) First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer. Eur. J. Nucl. Med. 21, 906-912.
27. 99mTc and evaluation as a possible tracer agent for ventriculography. J. Nucl. Biol. Med. 38(suppl), 75-78.
28. Wong G. L. M. (1991) Labelling of red blood cells with technetium-99m for nuclear medicine studies. Can. J. Hosp. Pharm. 44, 189-194.